COMBINATION THERAPY OF ETHINYLESTRADIOL AND ESTRAMUSTINE PHOSPHATE REINTRODUCES OBJECTIVE CLINICAL RESPONSE IN PATIENTS WITH ANDROGEN ABLATION-REFRACTORY PROSTATE CANCER (EARLY EXPERIENCE)